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Abstract
We have cloned a cDNA encoding a catalytic subunit of calcineurin (CnA) expressed in Xenopus oocytes. The deduced
amino acid sequence indicates 96.3% and 96.8% identities with the mouse and human CnAK isoforms, respectively. Xenopus
CnA (XCnA) RNA and protein are expressed as maternal and throughout development. Recombinant XCnA protein
interacted with calmodulin in the presence of Ca2. Deletion of calmodulin binding domain and auto-inhibitory domain
revealed calcium independent phosphatase activity, thereby showing that XCnA is likely to be modulated by both
calmodulin and calcium. ß 2000 Elsevier Science B.V. All rights reserved.
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In early embryogenesis, the inositol 1,4,5-trisphos-
phate (IP3)-Ca2 signal transduction pathway is in-
volved in many biological processes including fertil-
ization, cell cleavage and dorso^ventral axis
formation [1]. Although the importance of IP3-
Ca2 signaling has been appreciated, the immediate
target of free Ca2 has not been documented so far.
Calcineurin (Cn), a calcium/calmodulin (CaM) de-
pendent phosphatase 2B, is most abundant in brain,
but it is also detected in a wide variety of non-neuro-
nal tissues, and plays an important role in many bio-
logical processes including T-cell signal transduction
[2^8]. Cn has been implicated in the early events of
T-cell activation. In lymphoid cells, stimulation of
the T-cell receptor leads to the nuclear translocation
of the nuclear factor of activated T-cell (NF-AT)
family via activation of Cn, which in turn activate
immune response genes such as interleukin-2. This
process confers resistance to the immunosuppres-
sants, FK506 and cyclosporin A (CsA). It was shown
that the immunophilins, cyclophilin and FK506
binding protein (FKBP), which function as speci¢c
receptors for CsA and FK506, interact with Cn and
inhibit its activity, which in turn inhibits nuclear
translocation of NF-AT [9]. Recently, the Cn-NF-
AT pathway is also reported to be involved in non-
lymphoid cells and tissues [10^14]. This suggests that
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the Cn pathway has a variety of roles in both the
immune and non-immune systems.
In order to characterize the role of Cn during early
development, we cloned Xenopus CnA subunit
(XCnA) cDNA expressed in Xenopus oocytes, and
studied its expression pattern in Xenopus early em-
bryonic development.
We isolated the XCnA cDNA by using an EST
Fig. 1. (A) Comparison of the predicted amino acid sequence of the XCnA with that of mouse (GenBank accession number J05479;
mCnA) and human (L14778; hCnA). Amino acid residues identical to those of the Xenopus homologue are indicated by black boxes.
Conservatively substituted amino acid residues are indicated by shaded boxes. Catalytic domain is boxed with a line. CnB BD is
underlined with a solid line. CaM BD is underlined with a broken line. AID is underlined with asterisks. The nucleotide sequence of
XCnA is deposited in DDBJ/DMBL/GenBank DNA database under the accession number AB037146. (B) Comparison of splicing
sites of CnA isoforms. Splicing sites were compared among CnAK (human and murine [6], Xenopus [16]), CnAL [17,25], CnAQ iso-
forms (human [18] and mouse [26]) and D. melanogaster CnA [8]. Amino acid residues are numbered on the right.
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clone similar to mouse CnA (Intergrated Molecular
Analysis of Genome Expression, I.M.A.G.E., clone
ID, my38b01; GenBank database accession no.
AA239356) as a probe to screen a Xenopus oocyte
cDNA library [15]. The nucleotide sequence of
XCnA contains a presumptive ATG start codon pre-
ceded by 373 bp of 5P-£anking sequence, an open
reading frame encoding 508 amino acids, and 906
bp of 3P-untranslated sequence. The predicted molec-
ular weight of the full length peptide is 57.4 kDa, in
reasonable agreement with the value of V60 kDa
estimated by Western blot analysis (Fig. 3). The
cloned cDNA is 93.6% and 93.8% identical at the
amino acid level to murine CnAK [6] and human
CnAK [5], respectively. XCnA consists of four puta-
tive functional domains, which are ‘catalytic (resi-
dues 70^333) domain’, ‘regulatory domain’ that con-
tains the CnB binding domain (CnB BD) (residues
348^368), ‘CaM binding domain (CaM BD)’ (resi-
dues 391^414) and ‘auto-inhibitory’ domain (residues
457^480). The catalytic domain shows 96.3%, while
the other domains (CnB BD, CaM BD and auto-
inhibitory domain (AID)) show 100% amino acid
identities with those of both human and murine
CnA. Based on the high degree of similarity, we con-
cluded that this molecule was the Xenopus homo-
logue of CnA (XCnA). Recently, a splicing variant
form of XCnA expressed in Xenopus brain was re-
ported [16]. The XCnA cDNA expressed in Xenopus
brain has an insertion of 10 amino acids (amino
acids 447^456, accession no. AF019569), which is
absent in our present XCnA cDNA clone. These in-
sertions/deletions are found in exactly the same posi-
tion in mammalian CnAK [6], CnAL [17] and CnAQ
isoforms [18]. In Drosophila melanogaster, only the
10 amino acids CnA spliced-out form has been re-
ported [8] (Fig. 1B). It seems likely that the ancestral
gene for CnA obtained the 10 amino acid insertion
during the course of evolution into vertebrate. This
site is conserved among K-, L-, and Q-isoforms in
mammalians. CnA with the 10 amino acids has not
been found in adult and embryonic £y [8,19]. There-
fore, the spliced-in amino acids may have a role in
higher biological activities such as neural or immune
system that was gained during evolution. This is sup-
ported by our result that the major expression site of
the CnA spliced-in form is in brain (Fig. 2).
Based on this discrepancy, we designed a primer
pair to speci¢cally distinguish between these two
splicing variants by reverse transcription (RT)-PCR
Fig. 2. RNA pro¢le of XCnA in embryos. Schematic representation of the primer pair for detection of oocyte subtype (spliced-out
form) and brain subtype of XCnA transcripts (upper panel). Ten amino acid insert in brain type is indicated by boldface type. Amino
acid (aa) number is shown at both sides of the sequence. RT-PCR analysis of expression of XCnA in adult tissues and embryonic
stages (lower panel). The 315 bp PCR product corresponds to the brain subtype and the 285 bp band corresponds to the oocyte sub-
type. pCS2+MTXCnA is used as a control template (lane, pCSMTXCnA). Histone H4 is used as a loading control. 3RT, stage 8
embryo RNA without reverse transcription. Staging was according to Nieuwkoop and Faber [27].
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ampli¢cation, and examined tissue distribution and
developmental expression of these two subtypes of
transcripts by performing a semi-quantitative RT-
PCR [20]. The primers used are: up-stream primer,
5P-CTCCTCGAAGCTAGTGATCTTA-3P ; down-
stream primer, 5P-GTCCTTAGTATCTGCTCA-
GATG-3P. XCnA transcripts corresponding to the
present oocyte subtype (‘spliced-out’ form) or brain
subtype show sizes of 285 bp or 315 bp, respectively
(Fig. 2). Histone H4 was used as a loading control
(up-stream primer: 5P-CGGGATAACATTCAGGG-
TA-3P, down-stream primer: 5P-TCCATGGCGG-
TAACTGTC-3P). These semi-quantitative PCRs
were performed at 94‡C (30 s), 58‡C (10 s), 72‡C
(30 s) for 20^23 cycles using KODP polymerase
(Toyobo). For each set of primers, serial dilutions
of cDNA and cycle numbers required for the linear
range in the RT-PCR were determined empirically.
One fourth of the RT-PCR products were loaded
onto 5% non-denaturing polyacrylamide gel electro-
phoresis (PAGE) and the gels were overlaid with
DNA sensitive dye, SYBR Green I (Molecular
Probes), and analyzed using FluoroImager (Molecu-
lar Dynamics). A single band of 285 bp was ampli-
¢ed from XCnA oocyte cDNA (Fig. 2, lane: oocyte).
Two bands (315 bp and 285 bp) were ampli¢ed from
adult brain cDNA (Fig. 2, lane: brain). The spliced-
out form of XCnA (oocyte subtype) is expressed in
unfertilized eggs, and decreased gradually during
early cleavage stages. After gastrulation, the zygotic
XCnA (oocyte subtype) expression level increased
and reached a substantial level by tailbud stage of
stage 28 (Fig. 2). The ‘brain subtype’ ¢rst appeared
in tailbud stage, and increased gradually thereafter.
Skeletal muscle expressed a third subtype of RNA
(Fig. 2, lane: muscle). This muscle subtype was not
expressed during early stages of embryogenesis. Tak-
en together, the present XCnA is an alternative
spliced form of XCnA [16], which is expressed both
in early embryonic developmental stages and many
adult tissues.
In order to determine the size of the protein en-
coded by XCnA RNA and study XCnA protein ex-
pression pro¢le during embryonic stages, Western
blot analysis was performed using crude lysate of
Xenopus embryos overexpressing full length XCnA,
or myc-tagged XCnA (MTXCnA) RNA. The coding
region of XCnA was ampli¢ed by PCR. Primers used
are as follows: 5P up-stream primer including a StuI
restriction enzyme site, is 5P-AGGCCTTCTGAG-
CACAAGGCCAATGAAGC-3P ; 3P down-stream
primer including a XbaI site, is 5P-TCTAGAT-
CACTGAATATTGCTGCCGTTG-3P. The ampli-
¢ed fragment was subcloned into StuI and XbaI sites
of pCS2+ or pCS2+MT to generate pCS2+XCnA or
pCS2+MTXCnA. Crude lysates of Xenopus embryos
Fig. 3. Expression of XCnA protein in embryos. (A) Anti-hu-
man CnA recognizes endogenous XCnA or exogenously intro-
duced XCnA or XvCnA. RNA transcribed from pCS2+XvCnA,
pCS2+MTXvCnA, pCS2+XCnA or pCS2+MTXCnA was in-
jected into four blastomers of Xenopus four-cell stage embryos
at 4 ng per embryo. Ten Wg of crude lysates from stage 8 em-
bryos was loaded onto a 10% SDS^PAGE, and blotted with an
anti-human CnA antibody (Transduction Laboratories,
C26920). Anti-human CnA antibody recognized endogenous
XCnA in uninjected embryo (lanes, non). In embryos overex-
pressed with XCnA, a dense band of the same size was detected
(lane, XCnA). In embryos injected with XvCnA (lane,
XvCnA), myc-tagged XCnA (lane, MT-XCnA) or myc-tagged
XvCnA (lane, MT-XvCnA), additional bands corresponding to
the exogenously introduced RNA were detected. The bands cor-
responding to each exogenously introduced RNA are denoted
at the right. (B) Protein pro¢le of XCnA was analyzed by
Western blot analysis. Twenty Wg of crude lysates prepared
from indicated stages of embryos was loaded onto a 10% SDS^
PAGE, and blotted with an anti-human CnA antibody. Staging
was according to Nieuwkoop and Faber [27].
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at indicated stages were prepared as follows. Xenopus
embryos were homogenized in lysis bu¡er, contain-
ing 10 mM Tris, pH 7.5, 150 mM NaCl, 2 mM
EDTA, 2 mM EGTA, 1% Nonidet P-40, 4 mM
phenylmethylsulfonyl £uoride. The homogenate was
brie£y centrifuged at 1000Ug for 5 min and super-
natants were mixed with 2USDS^PAGE sample
bu¡er and boiled for 5 min, and were loaded onto
10% SDS^PAGE. A monoclonal antibody raised
against human CnA (Transduction Laboratories,
C26920) recognized both endogenously and exoge-
nously expressed XCnA (Fig. 3A). The XCnA pro-
tein pro¢le during developmental stages was ana-
lyzed by Western blot analysis using the same anti-
human CnA antibody (Fig. 3B). Interestingly, XCnA
protein was kept at a constant level compared to the
biphasic expression of XCnA RNA. The di¡erences
of expression pro¢les between XCnA RNA and pro-
tein may be due to di¡erence in stabilities between
RNA and protein, or post-transcriptional regulations
of XCnA.
The primary structure of XCnA indicates that
XCnA consists of a putative CaM BD, a CnB BD
and an AID (Fig. 1B). To con¢rm that XCnA was a
functional molecule, we performed CaM overlay and
phosphatase assays, and compared the activities be-
tween full length XCnA and XvCnA. We ¢rst pre-
pared bacterially expressed glutathione-S-transferase
(GST) fusion proteins with XCnA and a putative
constitutive active form, XvCnA (Fig. 4A). XvCnA
(amino acids 1^398 of XCnA) was generated by PCR
ampli¢cation. The 5P up-stream primer used was the
same as that used to generate full length XCnA. The
3P down-stream primer used was 5P-TCTAGAT-
CAGTTTCTGATAACTTCCTTTCGGG-3P which
included a XbaI site. For GST fusion protein pro-
duction, StuI and NotI fragments of
pCS2+MTXCnA or pCS2+MTXvCnA were sub-
cloned into pGEX4T-3 (Pharmacia) to generate
pGEX-XCnAFL or pGEX-XvCnA, respectively.
pGEX-XCnAFL or pGEX-XvCnA were trans-
formed into Escherichia coli BL21 (DE3). Recombi-
nant proteins were puri¢ed following the manufac-
turer’s instructions (Pharmacia). GST-XCnAFL and
XvCnA were resolved on 8% SDS^PAGE and then
electrophoretically transferred onto a PVDF mem-
brane (Millipore Corp.). The membrane was blocked
with blocking bu¡er (0.1 M NaCl, 50 mM Tris^HCl
(pH 7.5), 0.1% bovine serum albumin, 0.05% Tween
20) in the presence of 1 mM CaCl2 or 2 mM EGTA
for 30 min at room temperature. Biotinylated CaM
(Calbiochem) was added at a ¢nal concentration of
0.5 Wg/ml in the blocking bu¡er to the blotted mem-
brane and incubated for 30 min at room tempera-
ture. After washing with the blocking bu¡er, the
membranes were incubated with 1:5000 diluted avi-
Fig. 4. CaM binding activities and phosphatase activities of re-
combinant XCnA. (A) Puri¢ed GST fusion XCnAs were sepa-
rated by 8.0% SDS^PAGE and stained with Coomassie brilliant
blue R250 (lanes 1^3), or blotted onto a PVDF membrane
(lanes 4^9). The blots were reacted with a biotinylated CaM in
the presence of either 1 mM CaCl2 (lanes 4 and 5) or 1 mM
EGTA (lanes 6 and 7), or probed with an anti-human CnA
antibody (KCnA) (lanes 8 and 9). Molecular weight standard
was lane 1, GST-XCnAFL was lanes 2, 4, 6 and 8, GST-
XvCnA was lanes 3, 5, 7 and 9. (B) Protein phosphatase activ-
ities were measured using pNPP as a substrate at 30‡C for 30
min. Solid bars indicate the phosphatase activities in the pres-
ence of EGTA, white bars indicate in the presence of CaCl2.
Values are mean þ S.E.M. of triplicate experiments, each done
in duplicate.
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din-conjugated horseradish peroxidase (Prozyme) in
blocking bu¡er. The membranes were washed well
with blocking bu¡er, and developed with ECL
(Amersham). Wild type XCnA protein (GST-
XCnA) bound to biotinylated CaM in the presence
of Ca2 (lane 4), but not in the presence of EGTA
(lane 6). Whereas XvCnA, which was deleted with
CaM BD, did not bind to CaM (lanes 5 and 6). The
GST-tagged recombinant proteins apparently
showed larger molecular weights compared to their
intact molecules which was con¢rmed by Western
blot analysis using anti-human CnA (Fig. 4A, lanes
8 and 9). The enzymatic activity of XCnA was fur-
ther con¢rmed by a phosphatase assay (Fig. 4B).
CaM dependent phosphatase activity was measured
using p-nitro-phenyl-phosphate (pNPP) as a sub-
strate at 30‡C in 50 mM MOPS (pH 7.0), 6 mM
MgCl2, 0.5 mM CaCl2, 0.5 mM MnCl2, 0.03 WM
CaM, 1 mg/ml bovine serum albumin, 0.5 mM di-
thiothreitol and 1.0 WM okadaic acid. CaM inde-
pendent activity was done in the above bu¡er, in
which 1 mM EGTA was added instead of 0.5 mM
CaCl2. After incubation for 5 min at 30‡C, reactions
were initiated by the addition of pNPP at a ¢nal
concentration of 20 mM. After incubation for 30
min at 30‡C, the reactions were stopped by the ad-
dition of 0.5 M Na2CO3. GST-XCnAFL did not
show any phosphatase activity, probably due to the
absence of B-subunit (Fig. 4B). XvCnA, which was
deleted of CaM BD and AID, did not bind to CaM
(Fig. 4A), however showed phosphatase activity both
in the absence and the presence of Ca2. These re-
sults thereby suggest that XCnA shows Ca2 depen-
dent association with CaM, and that XvCnA func-
tions as a constitutive active mutant in that its
activity is independent of CaM and Ca2, as was
previously proposed with those of the mammalian
counterparts [2,21].
It is reported that CnA acts corporately with
FKBP to dephosphorylate the IP3R, which in turn
regulates the activity of IP3R [22,23]. We have pre-
viously reported that functional inhibition of XIP3R
in the ventral side of the embryo led to conversion of
ventral mesoderm to adopt a dorsal fate [20]. Nishi-
nakamura et al. reported that injection of Xenopus
FKBP into the ventral side of early stage embryo
induced an ectopic axis [24]. Taken together, these
lines of evidence suggest that FKBP-Cn may be in-
volved in dorso^ventral axis formation, possibly
through modi¢cation or as a result of the activation
of IP3R. However, the immunosuppressants, FK506
and CsA, did not show any e¡ect on the early em-
bryogenesis in Xenopus embryos (T.S. and S.K., un-
published data). Since yolk protein is abundant in
the embryo, these drugs might be non-speci¢cally
absorbed by yolk protein. Alternatively, the concen-
tration of FKBP or cyclophilin in the embryos was
insu⁄cient to inhibit endogenous XCnA.
In conclusion, we have cloned a splicing variant of
XCnA expressed in early embryonic development,
characterized its Ca2 dependent activities and ana-
lyzed its RNA and protein pro¢le. Further analysis is
needed to dissolve various aspects of CnA function
in early development including dorso^ventral axis
formation or neural development.
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